Medication info
Ajinpham K Tablets

Ajinpham K Tablets

OTC medicationTablet
Ingredient · strength
Diastase·Protease·Cellulase 1000›50mg / 1 tabletLactobacillus Sporogenes›15mg / 1 tabletLipase›30mg / 1 tabletPancreatin Enteric Coated Granules›70mg / 1 tabletSimethicone Powder›60mg / 1 tablet
Manufacturer / importer
일양약품(주)
Appearance
Orange rectangular film-coated tablets
Packaging
10 tablets/box [10 tablets/PTPX1]
Approval status
Active

MFDS item code 202401358 · Notified 2024.05.31

Summary

Main use
Improves dyspepsia and reduced appetite, alleviates abdominal bloating
Who uses it
Adults
Adult dosage
Adults aged 15 years and older take 1 tablet 3 times a day.

Ingredients

Manufacturer
일양약품(주)

Efficacy & effects

Improves dyspepsia and reduced appetite, alleviates abdominal bloating

  • Dyspepsia
  • reduced appetite
  • overeating
  • discomfort
  • abdominal bloating
  • constipation
  • loose stool
  • abdominal distension
  • abnormal intestinal fermentation
View approved original text

This medication helps to alleviate dyspepsia, anorexia, discomfort from overeating, and abdominal bloating. It is also used to promote digestion and relieve abdominal bloating and constipation or loose stool symptoms caused by abnormal fermentation in the intestines. Overall, it is effective in normalizing digestive function and maintaining intestinal health.

Dosage and Administration

Adult dosage

Adults aged 15 years and older take 1 tablet 3 times a day.

Precautions

This medication should not be taken by children under 7 years of age. Since this medication contains lactose, patients with hereditary galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. If you or your family members have a history of allergies, consult with a physician, dentist, or pharmacist before taking this medication. It is important for patients who are taking other medications or receiving treatment from a physician to consult with a professional before taking this medication. This medication contains Yellow No. 4 (Tartrazine) and Yellow No. 5 (Sunset Yellow FCF), so patients who are sensitive to or have a history of allergies to these substances should take caution. If symptoms do not improve after taking this medication for about 2 weeks, discontinue use immediately and consult a professional. This medication must be taken according to the prescribed dosage and dosage regimen; do not change the dosage arbitrarily. Store this medication in a safe place out of reach of children, in a tightly closed container away from direct sunlight, in a cool and dry place. Additionally, do not transfer this medication to another container; it should be stored in the original container to prevent misuse and maintain quality.

Storage

This medication should be stored in a sealed container to prevent air ingress, preferably at room temperature between 1 degrees Celsius and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Orange rectangular film-coated tablets

Package unit

10 tablets/box [10 tablets/PTPX1]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.